The Discounted Cash Flow (DCF) valuation of StageZero Life Sciences Ltd (SZLS.TO) is (6.17) CAD. With the latest stock price at 0.04 CAD, the upside of StageZero Life Sciences Ltd based on DCF is -15534.2%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.1% - 7.4% | 6.3% |
| Long-term Growth Rate | 3.0% - 4.9% | 3.9% |
| Fair Price | (55.95) - (3.36) | (6.17) |
| Upside | -139982.8% - -8493.4% | -15534.2% |